Dr Reddy’s to buy Haleon’s nicotine replacement therapy portfolio outside US
Mumbai: Drug major Dr. Reddy’s Laboratories will acquire British pharma company Haleon’s global portfolio of consumer healthcare brands in the nicotine replacement therapy category outside of the US for £500 million. The Indian company’s subsidiary Dr. Reddy’s Laboratories SA will acquire the share capital of Haleon plc’s arm Northstar Switzerland SARL for a total consideration … Read more